Home / Diltiazem / United States
US ATC C05AE03 · updated 2 Nov 2026
Diltiazem shortage in United States
Is there a Diltiazem shortage in United States?
Yes. As of 2 Nov 2026, 1 Diltiazem product is reported short in United States, the first since 5 Jan 2026. No return date has been given. Main reason: not stated.
Also short in France. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03) discontinuation | Hospira, Inc., a Pfizer Company | 5 Jan 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).